Appendix Xii B1 British Pharmacopoeia |verified| (2025)

. Specifically, B1 refers to the standard testing protocols and acceptance criteria used to evaluate whether a batch of medicine meets the required release profile. Drugfuture For most conventional-release products, the "Stage 1" or testing involves testing (e.g., six tablets). Key Acceptance Criteria (Level B1)

While the European Pharmacopoeia (Ph. Eur.) uses a similar method (2.9.17), the BP’s Appendix XII B1 contains unique notes on apparatus calibration, meniscus reading, and compliance criteria for small-volume parenterals (SVPs) and large-volume parenterals (LVPs). It applies to all sterile liquid dosage forms presented in single-dose or multi-dose containers. appendix xii b1 british pharmacopoeia